BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
China · Delayed Price · Currency is CNY 66.64
-1.92 (-2.80%)
At close: May 8, 2026
SHA:688166 Revenue
BrightGene Bio-Medical Technology had revenue of 324.93M CNY in the quarter ending March 31, 2026, with 30.52% growth. This brings the company's revenue in the last twelve months to 1.30B, up 9.09% year-over-year. In the year 2025, BrightGene Bio-Medical Technology had annual revenue of 1.22B, down -4.59%.
Revenue (ttm)
1.30B
Revenue Growth
+9.09%
P/S Ratio
21.67
Revenue / Employee
1.09M
Employees
1,196
Market Cap
28.16B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.22B | -58.91M | -4.59% |
| Dec 31, 2024 | 1.28B | 103.03M | 8.74% |
| Dec 31, 2023 | 1.18B | 162.19M | 15.94% |
| Dec 31, 2022 | 1.02B | -35.08M | -3.33% |
| Dec 31, 2021 | 1.05B | 267.03M | 34.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition